Source:http://linkedlifedata.com/resource/pubmed/id/20724382
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-10-4
|
pubmed:abstractText |
Long-term smokeless tobacco (ST) use is known to increase the risk for oropharyngeal cancer, heart attack, and stroke. Extant literature on cigarette smokers suggests that smoking reduction increases smoking abstinence among smokers not interested in quitting. Similarly, a reduction strategy may reduce ST exposure and increase ST abstinence rates among ST users not interested in quitting.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1469-994X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1037-40
|
pubmed:dateRevised |
2011-10-3
|
pubmed:meshHeading |
pubmed-meshheading:20724382-Adult,
pubmed-meshheading:20724382-Behavior,
pubmed-meshheading:20724382-Benzazepines,
pubmed-meshheading:20724382-Humans,
pubmed-meshheading:20724382-Male,
pubmed-meshheading:20724382-Middle Aged,
pubmed-meshheading:20724382-Nicotinic Agonists,
pubmed-meshheading:20724382-Quinoxalines,
pubmed-meshheading:20724382-Smoking Cessation,
pubmed-meshheading:20724382-Tobacco, Smokeless
|
pubmed:year |
2010
|
pubmed:articleTitle |
A pilot study to assess smokeless tobacco use reduction with varenicline.
|
pubmed:affiliation |
Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. ebbert.jon@mayo.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, N.I.H., Extramural
|